{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:17:52Z","timestamp":1768900672171,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.juro.2016.03.194","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T20:21:23Z","timestamp":1474489283000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction"],"prefix":"10.1097","volume":"197","author":[{"given":"Grant P.","family":"Redrow","sequence":"first","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas"},{"name":"Division of Urology, University of Texas at Houston School of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio A.","family":"Brausi","sequence":"additional","affiliation":[{"name":"Ausl Modena, Nuovo Ospendale Civile\u2013S. Agostino Estense, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario I.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Urology, Clinica Alemana de Santiago, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[{"name":"Division of Urology, McGill University Health Center, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis X.","family":"Keeley","sequence":"additional","affiliation":[{"name":"Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[{"name":"Department of Urology, U.T. Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[{"name":"Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[{"name":"Department of Urology, Groupe Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re, Assistance Publique Hopitaux de Paris, Faculty of Medicine Pierre et Marie Curie, Institut Universitaire de Canc\u00e9rologie GRC5, University Paris 6, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Thalmann","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Bern, Inselspital, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surena F.","family":"Matin","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.03.194_bib1","article-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","year":"2004"},{"key":"10.1016\/j.juro.2016.03.194_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.03.194_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00428-013-1378-4","article-title":"Different subtypes of carcinoma in situ of the bladder do not have a different prognosis","volume":"462","author":"Comp\u00e9rat","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.juro.2016.03.194_bib4","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2016.03.194_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.juro.2010.03.032","article-title":"Clinical outcomes of primary bladder carcinoma in situ in a contemporary series","volume":"184","author":"Chade","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette-Gu\u00e9rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.eururo.2012.02.042","article-title":"Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence","volume":"61","author":"Xylinas","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","article-title":"Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Gu\u00e9rin therapy","volume":"13","author":"Kojima","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2016.03.194_bib12","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","author":"Bossuyt","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2016.03.194_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-5347(17)47277-6","article-title":"Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin","volume":"134","author":"Herr","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1464-410x.2000.00610.x","article-title":"Bacillus Calmette-Gu\u00e9rin instillation treatment for carcinoma in situ of the upper urinary tract","volume":"85","author":"Nishino","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.03.194_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000020365","article-title":"Bacillus Calmette-Gu\u00e9rin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract","volume":"38","author":"Nonomura","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1464-410X.2001.02297.x","article-title":"Intrarenal bacillus Calmette-Gu\u00e9rin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure","volume":"88","author":"Okubo","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.03.194_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","article-title":"Intravesical instillation of bacille Calmette-Gu\u00e9rin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter","volume":"59","author":"Irie","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.03.194_bib18","first-page":"677","article-title":"Clinical outcome of bacillus Calmette-Gu\u00e9rin perfusion therapy for carcinoma in situ of the upper urinary tract","volume":"9","author":"Miyake","year":"2002","journal-title":"Int J\u00a0Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","article-title":"Long-term effects of bacille Calmette-Gu\u00e9rin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract","volume":"63","author":"Hayashida","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.03.194_bib20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1089\/end.2012.0229","article-title":"Outcomes of intrarenal bacillus Calmette-Gu\u00e9rin\/interferon-\u03b12B for biopsy-proven upper-tract carcinoma in situ","volume":"26","author":"Shapiro","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2016.03.194_bib21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.juro.2013.09.031","article-title":"Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upperurinary tract\u2014is there evidence for discordant biology?","volume":"191","author":"Krabbe","year":"2014","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2016.03.194_bib22","first-page":"e911","article-title":"Targeted sequencing of upper tract urothelial carcinoma","volume":"191","author":"Sfakianos","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1755-8794-3-58","article-title":"Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder","volume":"3","author":"Zhang","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.juro.2016.03.194_bib24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","volume":"30","author":"Wheat","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2016.03.194_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","article-title":"Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients","volume":"29","author":"Otto","year":"2011","journal-title":"World J\u00a0Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-012-0957-3","article-title":"Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study","volume":"31","author":"Xylinas","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2013.09.049","article-title":"Bacillus\u00a0Calmette-Gu\u00e9rin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist\u2019s failure to detect urothelial carcinoma of the upper urinary tract and urethra","volume":"65","author":"Giannarini","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.juro.2008.10.168","article-title":"Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis","volume":"181","author":"Wright","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/end.2009.0593","article-title":"Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience","volume":"25","author":"Traxer","year":"2011","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.juro.2016.03.194_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.aju.2012.01.006","article-title":"Accuracy of photodynamic diagnosis in the detection and follow-up of patients with upper urinary tract lesions: initial 3-year experience","volume":"10","author":"Aboumarzouk","year":"2012","journal-title":"Arab J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib33","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.juro.2013.08.006","article-title":"Volumetric in\u00a0vivo visualization of upper urinary tract tumors using optical coherence tomography: a\u00a0pilot study","volume":"190","author":"Bus","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11934-014-0437-y","article-title":"Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?","volume":"15","author":"Chen","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2016.03.194_bib35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7863\/jum.2010.29.9.1277","article-title":"High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma:\u00a0imaging findings and pathologic correlation","volume":"29","author":"Matin","year":"2010","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.juro.2016.03.194_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mla.2009.11.005","article-title":"Optical coherence tomography of the upper urinary tract: review of initial experience ex\u00a0vivo and in\u00a0vivo","volume":"25","author":"Mueller-Lisse","year":"2010","journal-title":"Med Laser Appl"},{"key":"10.1016\/j.juro.2016.03.194_bib37","first-page":"1063","article-title":"Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography","volume":"187","author":"Ren","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.urology.2011.02.057","article-title":"Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy","volume":"78","author":"Wu","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.03.194_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.03.194_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/end.2011.0426","article-title":"High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection","volume":"26","author":"Clements","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2016.03.194_bib41","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1089\/end.2013.0220","article-title":"Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps","volume":"27","author":"Kleinmann","year":"2013","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.juro.2016.03.194_bib42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.juro.2013.05.020","article-title":"Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer","volume":"190","author":"Sternberg","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib43","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","first-page":"119","article-title":"Urothelial carcinoma in situ","author":"Sesterhenn","year":"2004"},{"key":"10.1016\/j.juro.2016.03.194_bib44","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2016.03.194_bib45","first-page":"701","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.03.194_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.03.194_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2303.2007.00426.x","article-title":"Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses","volume":"18","author":"Garbar","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.juro.2016.03.194_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative\u00a0hydronephrosis, ureteroscopic biopsy\u00a0grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib49","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.ju.0000066842.45464.cc","article-title":"Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology","volume":"169","author":"Skacel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.03.194_bib50","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716313155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716313155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.03.194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:46:13Z","timestamp":1651207573000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.03.194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1016\/j.juro.2016.03.194"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.03.194","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.03.194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}